Patients with acute myocardial infarction and evidence of heart failure or left ventricular
dysfunction during the acute phase have an excessive mortality risk. Therapy with …

Background Angiotensin-converting-enzyme inhibitors improve the outcome among patients
with left ventricular dysfunction, whether or not they have heart failure. We assessed the role …

Despite the trend for a decrease in fatality rates due to coronary heart disease,
hospitalizations for acute myocardial infarction and its long term sequelae have remained …

Background We undertook a prospective systematic overview based on data from individual
patients from five long-term randomised trials that assessed inhibitors of angiotensin …

Persons with asymptomatic left ventricular (LV) systolic dysfunction after myocardial
infarction treated with blockers1, 2 or with angiotensin-converting enzyme (ACE) inhibitors3 …

Ischemic heart disease is the principal etiology of heart failure in the Western world.
Myocardial ischemia is important in cardiac remodeling, a process that leads to a …

This study was conducted to provide evidence of an association between angiotensin-
converting enzyme (ACE) inhibitor use and clinical outcomes among patients with …

Background: Several randomized, controlled trials show that angiotensin-converting enzyme
(ACE) inhibitors improve survival in patients who have had an acute myocardial infarction …

Objective.—To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on
mortality and morbidity in patients with symptomatic congestive heart failure. Data Sources …

Background. It is not known whether the treatment of patients with asymptomatic left
ventricular dysfunction reduces mortality and morbidity. We studied the effect of an …